Who’s involved?

The HEMO study is led by a team of health economists and statisticians at the London School of Hygiene and Tropical Medicine and is a collaboration with:

  • INTERVAL study trialists based at the University of Cambridge
  • Policy-makers at National Health Service Blood and Transplant (NHSBT)
  • Blood donors
  • Members of the public.

The study draws on the wide Management Group and a range of experts involved in the study. An Advisory Group, with an independent chair, oversees the study.

The Study Management Grouppeople transparent icon




Advisory Group

In addition to the members of the Study Management Group, the Advisory Group includes:

  • Chair – Prof Janet Powell (Imperial College)
  • London School of Hygiene and Tropical Medicine – Dr Simon Cohn
  • The INTERVAL study – Dr Carmel Moore, Prof David Roberts, Prof Simon Thompson
  • NHS Blood and Transplant: Dr Gail Miflin, Dr Gavin Cho, Crispin Wickenden, Laura Hontoria Del Hoyo
  • Public representative: Peter Zollman


Blood donors

Around 35,000 blood donors completed the surveys, and blood donors are also taking part in workshops to discuss the results.

Comments are closed.